Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short article: Evaluation of O6-methylguanine-DNA methyltransferase as a predicting factor of response to temozolomide-based chemotherapy in well-differentiated metastatic pancreatic neuroendocrine tumors.
Girot P, Dumars C, Mosnier JF, Muzellec L, Senellart H, Foubert F, Caroli-Bosc FX, Cauchin E, Regenet N, Matysiak-Budnik T, Touchefeu Y. Girot P, et al. Eur J Gastroenterol Hepatol. 2017 Jul;29(7):826-830. doi: 10.1097/MEG.0000000000000874. Eur J Gastroenterol Hepatol. 2017. PMID: 28328619
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors.
Girot P, Baudin E, Senellart H, Bouarioua N, Hentic O, Guimbaud R, Walter T, Ferru A, Roquin G, Cadiot G, Pracht M, Girot JB, Malka D, Ducreux M, Bennouna J, Matysiak-Budnik T, Hadoux J, Touchefeu Y. Girot P, et al. Neuroendocrinology. 2022;112(6):537-546. doi: 10.1159/000518650. Epub 2021 Jul 26. Neuroendocrinology. 2022. PMID: 34348346
Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer.
Touchefeu Y, Provost-Dewitte M, Lecomte T, Morel A, Valo I, Mosnier JF, Bossard C, Eugène J, Duchalais E, Chetritt J, Guyetant S, Bézieau S, Senellart H, Caulet M, Cauchin E, Matysiak-Budnik T. Touchefeu Y, et al. Eur J Gastroenterol Hepatol. 2016 Dec;28(12):1394-1399. doi: 10.1097/MEG.0000000000000725. Eur J Gastroenterol Hepatol. 2016. PMID: 27606947
Oncogenetic landscape of lymphomagenesis in coeliac disease.
Cording S, Lhermitte L, Malamut G, Berrabah S, Trinquand A, Guegan N, Villarese P, Kaltenbach S, Meresse B, Khater S, Dussiot M, Bras M, Cheminant M, Tesson B, Bole-Feysot C, Bruneau J, Molina TJ, Sibon D, Macintyre E, Hermine O, Cellier C, Asnafi V, Cerf-Bensussan N; CELAC network. Cording S, et al. Gut. 2022 Mar;71(3):497-508. doi: 10.1136/gutjnl-2020-322935. Epub 2021 Feb 12. Gut. 2022. PMID: 33579790 Free PMC article.
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Deleau C, Buecher B, Rousseau C, Kraeber-Bodéré F, Flamant M, des Varannes SB, Frampas E, Galmiche JP, Matysiak-Budnik T. Deleau C, et al. Eur J Gastroenterol Hepatol. 2011 Mar;23(3):275-81. doi: 10.1097/MEG.0b013e328343eaa0. Eur J Gastroenterol Hepatol. 2011. PMID: 21304319
Digestive cancer screening across Europe.
Burra P, Bretthauer M, Buti Ferret M, Dugic A, Fracasso P, Leja M, Matysiak Budnik T, Michl P, Ricciardiello L, Seufferlein T, van Leerdam M, Botos A. Burra P, et al. United European Gastroenterol J. 2022 May;10(4):435-437. doi: 10.1002/ueg2.12230. Epub 2022 Apr 26. United European Gastroenterol J. 2022. PMID: 35474447 Free PMC article. No abstract available.
108 results